UE Lifesciences organises cancer screening camp for Maharashtra Police: Our Bureau, Mumbai Thursday, January 29, 2026, 11:30 ...

India-EU FTA to expand reach of traditional medicine services & practitioners: Our Bureau, New Delhi Thursday, January 29, ...

Skyhawk Therapeutics announces interim results in patients from phase 1 clinical trial as a treatment for Huntington’s disease: Waltham, Massachusetts Thursday, January 29, 2026 ...

Independent Analyst values Vyome’s VT-1953 at USD 1 billion upon successful completion of phase 3 study: Our Bureau, Bengaluru Thursday, January 29, 2026, 17:30 Hrs [IST] Vyome ...

Our Bureau, New Delhi Thursday, January 29, 2026, 16:15 Hrs [IST] ...

Intuitive funds IIT Madras initiative to build affordable ultrasound imaging system for early breast cancer detection in rural India: Our Bureau, Bengaluru Thursday, January 29, 2 ...

Faron Pharma expands bexmarilimab programme in solid tumours with a randomized phase I/II BEXAR IIT in metastatic soft-tissue sarcoma: Turku, Finland Thursday, January 29, 2026, 1 ...

Happiest Diagnostics receives NABL accreditation for advanced diagnostics: Our Bureau, Bengaluru Thursday, January 29, 2026, 13:50 Hrs [IST] Happiest Diagnostics, a unit of Happie ...

ICON’s Accellacare site network expands oncology research capabilities with Brian Moran Cancer Institute: Dublin Thursday, January 29, 2026, 17:00 Hrs [IST] ICON plc, one of the ...

India-EU FTA strengthens regulatory cooperation for faster innovation in pharma and med-tech: Our Bureau, Bengaluru Thursday, January 29, 2026, 15:15 Hrs [IST] The India–EU Free ...

Swisslog Healthcare strengthens Asia Pacific growth ambitions with strategic expansion in India: Our Bureau, Bengaluru Thursday, January 29, 2026, 16:40 Hrs [IST] Swisslog Healthc ...

Chugai files regulatory application with MHLF for additional indication of Tecentriq to treat adjuvant therapy for MRD-positive bladder cancer: Tokyo Thursday, January 29, 2026, 0 ...